| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| GSK | GlaxoSmithKline PLC | $39.21 | $97.25B | N/A |
GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q1 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4258612-glaxosmithkline-plc-gsk-ceo-emma-walmsley-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare
May 01, 2019 - GlaxoSmithKline plc (NYSE:GSK) Q1 2019 Earnings Conference Call May 01, 2019 09:00 AM ET Company Participants Sarah Elton-Farr - Head, Investor Relations Emma Walmsley - Chief Executive Officer Iain M
0
Can Allergan (AGN) Beat Earnings Estimates Again in Q1?
http://www.zacks.com/stock/news/406700/can-allergan-agn-beat-earnings-estimates-again-in-q1?cid=CS-ZC-FT-406700
May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
0
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings?
http://www.zacks.com/stock/news/405507/whats-in-store-for-ani-pharmaceuticals-anip-q1-earnings?cid=CS-ZC-FT-405507
Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
0
What's in Store for BioSpecifics (BSTC) This Earnings Season?
http://www.zacks.com/stock/news/405553/whats-in-store-for-biospecifics-bstc-this-earnings-season?cid=CS-ZC-FT-405553
Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.
0
Teva (TEVA) to Report Q1 Earnings: What's in the Cards?
http://www.zacks.com/stock/news/405122/teva-teva-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-405122
Apr 29, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Teva's (TEVA) sales in Q1.
0
Is a Beat in Store for Glaxo (GSK) This Earnings Season?
http://www.zacks.com/stock/news/404550/is-a-beat-in-store-for-glaxo-gsk-this-earnings-season?cid=CS-ZC-FT-404550
Apr 26, 2019 - Strong sales of Glaxo's (GSK) Vaccines segment is likely to drive the top line in the first quarter.
0
Novartis (NVS) Q1 Earnings Beat Estimates, Revenues Up Y/Y
http://www.zacks.com/stock/news/394696/novartis-nvs-q1-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-394696
Apr 24, 2019 - Novartis (NVS) beats on Q1 earnings, sales marginally miss estimates.
0
What's in Store for Celgene Corporation (CELG) Q1 Earnings?
http://www.zacks.com/stock/news/391205/whats-in-store-for-celgene-corporation-celg-q1-earnings?cid=CS-ZC-FT-391205
Apr 23, 2019 - Investors are looking forward to Revlimid's performance and updates on the impending acquisition agreement with Bristol-Myers, when Celgene Corporation (CELG) reports Q1 results.
0
Are Investors Undervaluing GlaxoSmithKline (GSK) Right Now?
http://www.zacks.com/stock/news/390851/are-investors-undervaluing-glaxosmithkline-gsk-right-now?cid=CS-ZC-FT-390851
Apr 23, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
What's in Store for Bayer (BAYRY) This Earnings Season?
http://www.zacks.com/stock/news/390421/whats-in-store-for-bayer-bayry-this-earnings-season?cid=CS-ZC-FT-390421
Apr 22, 2019 - Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.
0